Related Experiment Video
Updated: Aug 5, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
[Percutaneous radiotherapy for thyroid gland carcinoma]
Radiobiologia, Radiotherapia
|January 1, 1989
Summary
Percutaneous radiotherapy outcomes for thyroid carcinoma depend on tumor histology and spread. Differentiated tumors and early stages show better survival, while advanced or dedifferentiated cancers require radiotherapy for palliative care.
Area of Science:
- Oncology
- Radiotherapy
- Medical Physics
Context:
- Retrospective analysis of 86 thyroid carcinoma patients treated between 1972-1982.
- Evaluation of therapeutic outcomes and prognostic factors for percutaneous radiotherapy.
Purpose:
- To analyze prognostically relevant factors in thyroid carcinoma.
- To determine indications for percutaneous radiotherapy in thyroid cancer treatment.
Summary:
- Tumor histology significantly impacts prognosis: 5-year survival was 83% for differentiated and 22% for dedifferentiated carcinomas.
- Locoregional tumor spread is critical: 5-year survival decreased from 83% (T1-3N0M0) to 57% with lymph node metastasis and 23.5% with extranodal spread.
- Postoperative radiotherapy is recommended for lymph node metastasis; palliative radiotherapy is indicated for large, inoperable tumors.
Impact:
- Highlights the importance of histological differentiation and tumor stage in predicting thyroid cancer outcomes.
- Supports the use of percutaneous radiotherapy in specific clinical scenarios, including adjuvant therapy and palliative care.
- Provides evidence-based insights for refining treatment strategies and improving patient management in thyroid carcinoma.
